Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DI6C5V
|
|||
| Drug Name |
V116
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Pneumococcal infection [ICD-11: CA00-CA40] | Phase 3 | [1] | |
| Company |
Merck
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05425732) A Phase 3, Randomized, Double-blind, Active Comparator-controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-na?ve Adults. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.